Diabetes Drug Delivery Devices Market is projected to be worth USD 31 billion by 2030

Roots Analysis has announced the addition of “Diabetes Drug Delivery Devices Market, 2020-2030” report to its list of offerings.
Stakeholders engaged in this domain are presently focusing on introducing advanced features, such as integrated continuous glucose monitoring (CGM) systems, artificial intelligence (AI) enabled algorithms, provisions for audiovisual / tactile feedback, and automatic drug reconstitution features. Such efforts are primarily directed towards differentiating proprietary offerings within a highlight competitive market landscape, and are expected to drive the market’s growth over the coming years.
Key Market Insights
More than 80 diabetes drug delivery devices are presently available / under development
More than 65% of the aforementioned devices are marketed, while the rest are being evaluated in preclinical / clinical studies. It is also worth highlighting that majority of the drug delivery devices intended for diabetics are insulin pumps (35%), followed by pen injectors / autoinjectors (32%).

Leave a Reply

Your email address will not be published. Required fields are marked *